Bringing Discoveries to Commercialization
Indiana Center for Biomedical Innovation interns wrap up summer session


Indiana Center for Biomedical Innovation interns wrap up summer session

Friday, August 30, 2019

Interns and mentors are finishing their summer research with the Indiana Center for Biomedical Innovation (ICBI) this month. The program supports Indiana Clinical and Translational Sciences Institute’s goal of teaching undergraduate students while giving them hands-on training in translational research and entrepreneurship. Read more…

ICBI company, Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy

Friday, August 30, 2019

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced that they are a recipient of a Phase II SBIR grant from the National Institutes of Health (NIH) for $2.3 million. The Phase II award is to continue to support the research with Scioto’s collaborator, the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital in Columbus, Ohio. The funding will be used to develop Scioto’s proprietary therapeutic SB-121, which is a unique formulation used to deliver healthy, activated probiotic or beneficial bacteria to the gastrointestinal tract. Scioto’s strategy of delivering healthy bacteria to the GI tract can be used to treat a number of different disorders ranging from infectious diseases to disorders effecting the gut-brain axis, such as autism and depression.

Dr. Timothy Hsiao, Program Director at the National Center for Advancing Translational Sciences (NCATS) visited the CTSI incubator, Indiana Center for Biomedical Innovation (ICBI)

Friday, August 30, 2019

The federal government provides various supports for health ventures to strengthen the country’s public health and innovation-driven economy. Dr. H. Timothy Hsiao, the Program Director at the National Center for Advancing Translational Sciences, discussed NIH’s relevant sources of funding and technical assistance, including but not limited to the: Small Business Technology Transfer (R41/R42), Small Business Innovation Research (R43/R44), Research Project Cooperative Agreement (U01). He also, discussed the grant-winning strategies to navigate the NIH funding system to increase the funding success rate.

Q2 Solutions open house ​at the ICBI

Friday, August 30, 2019

Meet the Q2 solutions team at the Indiana Center for Biomedical Innovation (ICBI), Thursday, May 23rdat noon

 Q2 Solutions is a global clinical trial laboratory service organization

Early Hit-to-Lead ADME Screening Services offered by Q2

Invention to Startup forum, February 7, 2019

Friday, August 30, 2019

Indiana Center for Biomedical Innovation (ICBI) is hosting an “Invention to Startup forum 

The goal of the Invention to Startup forum is to support advancement of translational research and lab discoveries to enable formation of startup companies.  The forum is designed to provide guidance and mentorship to academic scientists.

Dr. Timothy Corson will talk about the “Novel compounds and targets for blocking neovascularization”.

Dr. Corson is an associate professor in the Department of Ophthalmology, Showalter Scholar and Director of Basic and Translational Research in the Eugene and Marilyn Glick Eye Institute. He is also a member of the IU Melvin and Bren Simon Cancer Center, Stark Neurosciences Research Institute, and Center for Diabetes and Metabolic Diseases

Allinaire Therapeutics Receives Significant Funding

Friday, August 30, 2019

Allinaire Therapeutics, a respiratory therapeutics start-up launched by BioMotiv, has recently received new investments from BioCrossroads’ Indiana Seed Fund and Indiana University’s Innovate Indiana Fund. The Funding will advance the development of therapeutics for the treatment of chronic obstructive pulmonary disorder (COPD) and other respiratory diseases. Read Now

ICBI startup company, Anagin received $3 million NIHM grant for a new PTSD Medication

Friday, August 30, 2019

A $3 million NIHM grant provides support for a new PTSD Medication Part 2 of a series tracking the development of a safer, new PTSD… Read Now

ICBI startup company, Theratome Bio moves toward trials for stroke remedy

Friday, August 30, 2019

Theratome Bio said it plans to begin manufacturing small doses of the experimental drug and start clinical trials on patients in the first half of 2019. The plan is to administer the drugs to 24 patients who are undergoing a transaortic valve replacement, a minimally invasive surgical procedure that repairs the valve. Brain injury is a significant complication of the procedure. The company, formerly known as NeuroFx, had previously raised about $2 million, chiefly from Ambassador Enterprises of Fort Wayne. Theratome Bio, is based at the Indiana Center for Biomedical Innovation at Methodist Hospital downtown with six employees and consultants, .  Read Now.

Invention to Startup forum Friday, October 27th, 2017

Friday, August 30, 2019

You are invited to the “Invention to Startup forum” at The Indiana Center of Biomedical Innovation (ICBI). The goal of the program is to support the advancement of translational research and lab discoveries into market-directed healthcare applications.  The program is designed to provide guidance and mentorship to academic scientists.


The next forum meeting is on  October 27th , see information below.


Speakers: Terry Loghmani, Ph.D. PT & Colleagues

Talk: Quantifiable Soft Tissue Manipulation Technology: A New Frontier in Manual Therapy

When: Friday, October 27th, 2017 12:30-1:30 PM

Where: Indiana Center for Biomedical Innovation (ICBI)


Google directions to ICBI: Directions to ICBI


If you are interested, please register, Invention to Startup Forum

Calling all entrepreneurial researchers!

Friday, August 30, 2019

I-CORPS Training
• When: Oct. 19-20 and Nov. 17
• Where: HITS building at IUPUI
• Summary: The “Introduction to Customer Discovery” course is a medical- and healthcare-focused program to help researchers and clinicians discover the commercial potential of their innovations.

Apply by Sept. 22:

AWARE Commercialization and Entrepreneurship Summit
• When: Oct. 5
• Where: Hine Hall at IUPUI
• Summary: This NSF-supported event aims to help researchers navigate competitive SBIR/STTR funding mechanisms. It is specifically targeted to female and minority scientists, and open to all.

Register by Sept. 29